These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 21270531)

  • 1. A non-glycosylated, plant-produced human monoclonal antibody against anthrax protective antigen protects mice and non-human primates from B. anthracis spore challenge.
    Mett V; Chichester JA; Stewart ML; Musiychuk K; Bi H; Reifsnyder CJ; Hull AK; Albrecht MT; Goldman S; Baillie LW; Yusibov V
    Hum Vaccin; 2011; 7 Suppl():183-90. PubMed ID: 21270531
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Production of Functionally Active and Immunogenic Non-Glycosylated Protective Antigen from Bacillus anthracis in Nicotiana benthamiana by Co-Expression with Peptide-N-Glycosidase F (PNGase F) of Flavobacterium meningosepticum.
    Mamedov T; Chichester JA; Jones RM; Ghosh A; Coffin MV; Herschbach K; Prokhnevsky AI; Streatfield SJ; Yusibov V
    PLoS One; 2016; 11(4):e0153956. PubMed ID: 27101370
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A plant-produced protective antigen vaccine confers protection in rabbits against a lethal aerosolized challenge with Bacillus anthracis Ames spores.
    Chichester JA; Manceva SD; Rhee A; Coffin MV; Musiychuk K; Mett V; Shamloul M; Norikane J; Streatfield SJ; Yusibov V
    Hum Vaccin Immunother; 2013 Mar; 9(3):544-52. PubMed ID: 23324615
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Neutralizing monoclonal antibody to edema toxin and its effect on murine anthrax.
    Winterroth L; Rivera J; Nakouzi AS; Dadachova E; Casadevall A
    Infect Immun; 2010 Jun; 78(6):2890-8. PubMed ID: 20385755
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Human-derived, plant-produced monoclonal antibody for the treatment of anthrax.
    Hull AK; Criscuolo CJ; Mett V; Groen H; Steeman W; Westra H; Chapman G; Legutki B; Baillie L; Yusibov V
    Vaccine; 2005 Mar; 23(17-18):2082-6. PubMed ID: 15755575
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Human monoclonal antibodies against anthrax lethal factor and protective antigen act independently to protect against Bacillus anthracis infection and enhance endogenous immunity to anthrax.
    Albrecht MT; Li H; Williamson ED; LeButt CS; Flick-Smith HC; Quinn CP; Westra H; Galloway D; Mateczun A; Goldman S; Groen H; Baillie LW
    Infect Immun; 2007 Nov; 75(11):5425-33. PubMed ID: 17646360
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prophylaxis and therapy of inhalational anthrax by a novel monoclonal antibody to protective antigen that mimics vaccine-induced immunity.
    Vitale L; Blanset D; Lowy I; O'Neill T; Goldstein J; Little SF; Andrews GP; Dorough G; Taylor RK; Keler T
    Infect Immun; 2006 Oct; 74(10):5840-7. PubMed ID: 16988263
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Monoclonal antibody against the poly-gamma-D-glutamic acid capsule of Bacillus anthracis protects mice from enhanced lethal toxin activity due to capsule and anthrax spore challenge.
    Jang J; Cho M; Lee HR; Cha K; Chun JH; Hong KJ; Park J; Rhie GE
    Biochim Biophys Acta; 2013 Mar; 1830(3):2804-12. PubMed ID: 23201204
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A plant based protective antigen [PA(dIV)] vaccine expressed in chloroplasts demonstrates protective immunity in mice against anthrax.
    Gorantala J; Grover S; Goel D; Rahi A; Jayadev Magani SK; Chandra S; Bhatnagar R
    Vaccine; 2011 Jun; 29(27):4521-33. PubMed ID: 21504775
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Functional analysis of Bacillus anthracis protective antigen by using neutralizing monoclonal antibodies.
    Brossier F; Lévy M; Landier A; Lafaye P; Mock M
    Infect Immun; 2004 Nov; 72(11):6313-7. PubMed ID: 15501759
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Monoclonal antibody therapies against anthrax.
    Chen Z; Moayeri M; Purcell R
    Toxins (Basel); 2011 Aug; 3(8):1004-19. PubMed ID: 22069754
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In vitro and in vivo characterization of anthrax anti-protective antigen and anti-lethal factor monoclonal antibodies after passive transfer in a mouse lethal toxin challenge model to define correlates of immunity.
    Staats HF; Alam SM; Scearce RM; Kirwan SM; Zhang JX; Gwinn WM; Haynes BF
    Infect Immun; 2007 Nov; 75(11):5443-52. PubMed ID: 17709410
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mucosal immunization with a novel nanoemulsion-based recombinant anthrax protective antigen vaccine protects against Bacillus anthracis spore challenge.
    Bielinska AU; Janczak KW; Landers JJ; Makidon P; Sower LE; Peterson JW; Baker JR
    Infect Immun; 2007 Aug; 75(8):4020-9. PubMed ID: 17502384
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Questionable Efficacy of Therapeutic Antibodies in the Treatment of Anthrax.
    Tournier JN; Rougeaux C; Biot FV; Goossens PL
    mSphere; 2019 Jun; 4(3):. PubMed ID: 31217301
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Microbiology. A binding contract for anthrax.
    Bull JJ; Parrish CR
    Science; 2002 Jul; 297(5579):201-2. PubMed ID: 12114612
    [No Abstract]   [Full Text] [Related]  

  • 16. Passive Immunotherapy Protects against Enteric Invasion and Lethal Sepsis in a Murine Model of Gastrointestinal Anthrax.
    Huang B; Xie T; Rotstein D; Fang H; Frucht DM
    Toxins (Basel); 2015 Sep; 7(10):3960-76. PubMed ID: 26426050
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Adenoviral Expression of a Bispecific VHH-Based Neutralizing Agent That Targets Protective Antigen Provides Prophylactic Protection from Anthrax in Mice.
    Moayeri M; Tremblay JM; Debatis M; Dmitriev IP; Kashentseva EA; Yeh AJ; Cheung GY; Curiel DT; Leppla S; Shoemaker CB
    Clin Vaccine Immunol; 2016 Jan; 23(3):213-8. PubMed ID: 26740390
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A high-affinity monoclonal antibody to anthrax protective antigen passively protects rabbits before and after aerosolized Bacillus anthracis spore challenge.
    Mohamed N; Clagett M; Li J; Jones S; Pincus S; D'Alia G; Nardone L; Babin M; Spitalny G; Casey L
    Infect Immun; 2005 Feb; 73(2):795-802. PubMed ID: 15664918
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Passive vaccination with a human monoclonal antibody: generation of antibodies and studies for efficacy in Bacillus anthracis infections.
    vor dem Esche U; Huber M; Zgaga-Griesz A; Grunow R; Beyer W; Hahn U; Bessler WG
    Immunobiology; 2011 Jul; 216(7):847-53. PubMed ID: 21397977
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Generation of protective immune response against anthrax by oral immunization with protective antigen plant-based vaccine.
    Gorantala J; Grover S; Rahi A; Chaudhary P; Rajwanshi R; Sarin NB; Bhatnagar R
    J Biotechnol; 2014 Apr; 176():1-10. PubMed ID: 24548460
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.